Glycoscience, Disease, and Clinical Practice Symposium Will Be Held January 24
The NCI-funded Alliance of Glycobiologists for Detection of Cancer and Cancer Risk will host a symposium on January 24, entitled "Interfacing Glycoscience with Disease and Clinical Practice." The symposium will take place at the Natcher Conference Center on the NIH main campus in Bethesda, MD, from 8:30 a.m. to 4:30 p.m.
The symposium will highlight key developments in our understanding of how sugars are used to make complex structures critical for many life functions and provide examples of how these developments are informing areas such as disease treatment and prevention. Presentations will emphasize the many ways glycans and their binding proteins influence fundamental biological processes and how these discoveries are advancing medicine.
- Dr. John Magnani, GlycoMimetics, Inc.
- Dr. Ira Pastan, NCI
- Dr. Robert Sackstein, Harvard Medical School
- Dr. Carole Bewley, National Institute of Diabetes and Digestive and Kidney Diseases
- Dr. Ronald Schnaar, Johns Hopkins University
- Dr. Robert Haltiwanger, SUNY Stony Brook
- Dr. Richard Cummings, Emory University
- Dr. Michael Pierce, University of Georgia
- Dr. David Walt, Tufts University
The agenda is online, and advanced registration is not required. Questions regarding the symposium may be directed to Dr. Karl Krueger at 301-594-1044 or via e-mail at NCIGlycomicsAlliance@mail.nih.gov.
Sign language interpreters will be provided. Individuals with disabilities who need reasonable accommodation to participate in this meeting should contact Annalisa Gnoleba at 301-594-7635 or firstname.lastname@example.org.
Cyber-Seminar to Address the Delivery of Patient-Centered Cancer Care
The January 24 Research-to-Reality (R2R) cyber-seminar will focus on new accreditation standards recently released by the American College of Surgeons' Commission on Cancer (CoC).
These standards aim to ensure that key elements of quality cancer care are provided to every person treated in a CoC-accredited facility. They also challenge cancer programs to address patient-centered needs and to measure the quality of the care they provide against national standards.
Connie Bura, administrative director of Cancer Programs at the CoC, and Dr. Teresa Ponn, of the New Hampshire Comprehensive Cancer Control Collaboration, will outline the evidence for and details of the new patient-centered standards and include strategies to link the patient-centered standards and their implementation at the community level with the objectives of comprehensive cancer control plans.
For more information and to register for this event, visit the R2R website, where you can watch presentations and join discussions. All R2R cyber-seminars are archived on the website approximately 1 week after the presentation.
Genomics in Medicine Series Features Two Lectures on Cancer
Last month, the National Human Genome Research Institute (NHGRI); Suburban Hospital in Bethesda, MD; and the Johns Hopkins University School of Medicine jointly launched a lecture series to improve participants' understanding of the intersection of genomics and medicine.
Last week, Dr. Lawrence Brody of NHGRI delivered a lecture on how knowledge of breast cancer genetics has influenced risk assessment and screening. A video archive will soon be available on NHGRI's YouTube channel.
The next lecture, on February 3, will feature Dr. Stanley Lipkowitz of NCI's Laboratory of Cellular and Molecular Biology speaking on how genomic characterization of breast cancer is used in diagnosis and treatment.
For more information on upcoming speakers, visit the series' webpage. Lectures take place at 8:00 a.m. on the first Friday of each month at the Suburban Hospital Auditorium, 8600 Old Georgetown Road, Bethesda, MD.